Kissei Pharmaceutical

¥3,665As of Sun 8 Nov 2026, 12:00 UTC

TSE:4547Healthcare

Country Japan

PE (Fwd) 10.07

TSR 10Y CAGR 5.48%

Div yield 3.27%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) (0.14)

PE TTM 11.05

TSR TTM (4.41%)

Mkt cap ¥151.6B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

¥3,709

1.21%

66.75%

Price below Reference Value

TTM

FYE 31 Mar JPY

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

97.41

Revenue¥B

—

65.38

67.49

75.58

88.33

97.41

103.1

10.48%

10.28

Revenue growth%

—

3.23

11.98

16.87

10.28

5.85

11.13

—

47.04

Gross margin%

—

47.78

47.97

49.41

49.89

47.04

47.05

47.97

(3.00)

Operating margin%

—

(2.14)

(1.69)

5.31

6.54

(3.00)

(2.99)

(1.69)

14.15

Net margin%

—

19.76

15.60

14.77

13.54

14.15

14.02

14.77

11.05

P/E ratio (avg)x

—

8.292

11.36

12.88

13.29

13.27

10.54

12.88

—

EV/EBITx

—

35.79

27.52

—

31.66

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

331.53

EPS¥

—

280.19

228.30

246.58

274.20

331.53

347.68

4.30%

—

20.91

EPS growth%

—

(18.52)

8.01

11.20

20.91

4.87

9.60

—

Bookvalue per sh¥

—

FCF per share¥

—

120.00

Dividend per sh¥

—

56.00

80.00

82.00

100.00

120.00

127.68

20.99%

—

3.27

Div yield (avg)%

—

2.41

3.08

2.58

2.74

2.73

3.48

2.73

36.20

Payout ratio%

—

19.99

35.04

33.25

36.47

36.20

36.72

35.04

41.38

Shares (diluted)M

—

46.12

45.26

43.62

41.56

◌41.56

(2.57%)

4.72

Buyback yield%

—

1.86

3.62

4.72

◌—

2.74

—

D/E ratiox

—

151.6

Enterprise value¥B

—

107.1

119.6

143.8

158.9

182.9

152.3

14.30%

—

LT debt¥M

—

Peers (US$962.8M)

Cap (US$)

Sawai Group Holdings…

1.199B

23.70x

Towa Pharmaceutical…

1.035B

19.71x

Kaken Pharmaceutical…

899.2M

13.73x

Jiangsu Yahong…

962.3M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(104.5)

(57.15)

Own earn%

—

Sh yield%

8.00

5.40

Owners

Insiders/Inst%

3.99

32.99

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

4/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

−3–7

$1 testx

—

Incr. ROIC%

—

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

¥97.41B

10.48%

1.00×

Cost of revenue

¥51.59B

10.87%

1.01×

Operating expenses

¥48.74B

10.55%

1.00×

Revenue by region

No breakdown available

Reinvestment returns

No breakdown available